American Century Companies
KRTX

American Century Companies’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

American Century Companies’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-45,064
Closed -$14.3M – 2978
2023
Q4 		$14.3M Buy
45,064
+823
+2% +$160K 0.01% 996
2023
Q3 		$7.48M Sell
44,241
-782
-2% -$147K 0.01% 1171
2023
Q2 		$9.76M Sell
45,023
-36,246
-45% -$7.77M 0.01% 1059
2023
Q1 		$14.7M Buy
81,269
+10,235
+14% +$1.96M 0.01% 872
2022
Q4 		$14M Buy
71,034
+2,121
+3% +$455K 0.01% 849
2022
Q3 		$15.5M Sell
68,913
-13,951
-17% -$2.82M 0.01% 739
2022
Q2 		$10.5M Sell
82,864
-46,413
-36% -$5.33M 0.01% 890
2022
Q1 		$16.4M Sell
129,277
-546
-0.4% -$61.5K 0.01% 752
2021
Q4 		$17M Buy
129,823
+2,152
+2% +$278K 0.01% 738
2021
Q3 		$15.6M Sell
127,671
-235
-0.2% -$27.1K 0.01% 734
2021
Q2 		$14.6M Sell
127,906
-9,705
-7% -$1.13M 0.01% 732
2021
Q1 		$16.5M Sell
137,611
-2,765
-2% -$313K 0.01% 679
2020
Q4 		$14.3M Buy
140,376
+8,343
+6% +$773K 0.01% 694
2020
Q3 		$10.2M Buy
132,033
+53,290
+68% +$4.54M 0.01% 710
2020
Q2 		$8.78M Buy
+78,743
New +$6.85M 0.01% 705

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

American Century Companies's KRTX Position: Q1 2024 in Review

American Century Companies sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 45,064 shares — an estimated $14.3M sold.

American Century Companies first reported a position in KRTX in Q2 2020 and held it in 15 quarters. The position peaked at $17M in Q4 2021. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • American Century Companies reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • American Century Companies sold 45,064 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $14.3M.
  • American Century Companies first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • American Century Companies's Karuna Therapeutics, Inc. Common Stock position peaked at $17M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.